| [1] |
Vincent JL, De Backer D. Circulatory shock[J]. N Engl J Med, 2013, 369(18):1726–1734.
|
| [2] |
Rivers EP, Kruse JA, Jacobsen G, et al. The influence of early hemodynamic optimization on biomarker patterns of severe sepsis and septic shock[J]. Crit Care Med, 2007, 35(9):2016–2024.
|
| [3] |
Corrêa TD, Vuda M, Blaser AR, et al. Effect of treatment delay on disease severity and need for resuscitation in porcine fecal peritonitis[J]. Crit Care Med, 2012, 40(10):2841–2849.
|
| [4] |
Weil MH, Shubin H. The "VIP" approach to the bedside management of shock[J]. JAMA, 1969, 207(2):337–340.
|
| [5] |
Marik PE, Cavallazzi R, Vasu T, et al. Dynamic changes in arterial waveform derived variables and fluid responsiveness in mechanically ventilated patients: a systematic review of the literature[J]. Crit Care Med, 2009, 37(9):2642–2647.
|
| [6] |
Cavallaro F, Sandroni C, Marano C, et al. Diagnostic accuracy of passive leg raising for prediction of fluid responsiveness in adults: systematic review and meta-analysis of clinical studies[J]. Intensive Care Med, 2010, 36(9):1475–1483.
|
| [7] |
Delaney AP, Dan A, McCaffrey J, et al. The role of albumin as a resuscitation fluid for patients with sepsis: a systematic review and meta-analysis[J]. Crit Care Med, 2011, 39(2):386–391.
|
| [8] |
Dellinger RP, Levy MM, Rhodes A, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2012[J]. Crit Care Med, 2013, 41(2):580–637.
|
| [9] |
Bellomo R, Chapman M, Finfer S, et al. Low-dose dopamine in patients with early renal dysfunction: a placebo-controlled randomised trial. Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group[J]. Lancet, 2000, 356(9248):2139–2143.
|
| [10] |
De Backer D, Biston P, Devriendt J, et al. Comparison of dopamine and norepinephrine in the treatment of shock[J]. N Engl J Med, 2010, 362(9):779–789.
|
| [11] |
De Backer D, Aldecoa C, Njimi H, et al. Dopamine versus norepinephrine in the treatment of septic shock: a meta-analysis[J]. Crit Care Med, 2012, 40(3):725–730.
|
| [12] |
Levy B, Perez P, Perny J, et al. Comparison of norepinephrine-dobutamine to epinephrine for hemodynamics, lactate metabolism, and organ function variables in cardiogenic shock: A prospective, randomized pilot study[J]. Crit Care Med, 2011, 39(3):450–455.
|
| [13] |
Annane D, Vignon P, Renault A, et al. Norepinephrine plus dobutamine versus epinephrine alone for management of septic shock: a randomised trial[J]. Lancet, 2007, 370(9588):676–684.
|
| [14] |
Myburgh JA, Higgins A, Jovanovska A, et al. A comparison of epinephrine and norepinephrine in critically ill patients[J]. Intensive Care Med, 2008, 34(12):2226–2234.
|
| [15] |
TRIUMPH Investigators, Alexander JH, Reynolds HR, et al. Effect of tilarginine acetate in patients with acute myocardial infarction and cardiogenic shock: the TRIUMPH randomized controlled trial[J]. JAMA, 2007, 297(15):1657–1666
|
| [16] |
López A, Lorente JA, Steingrub J, et al. Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock[J]. Crit Care Med, 2004, 32(1):21–30.
|
| [17] |
Russell JA, Walley KR, Singer J, et al. Vasopressin versus norepinephrine infusion in patients with septic shock[J]. N Engl J Med, 2008, 358(9):877–887.
|
| [18] |
Russell JA, Walley KR, Gordon AC, et al. Interaction of vasopressin infusion, corticosteroid treatment, and mortality of septic shock[J]. Crit Care Med, 2009, 37(3):811–818.
|
| [19] |
De Backer D, Creteur J, Dubois MJ, et al. The effects of dobutamine on microcirculatory alterations in patients with septic shock are independent of its systemic effects[J]. Crit Care Med, 2006, 34(2):403–408.
|
| [20] |
Jansen TC, van Bommel J, Schoonderbeek FJ, et al. Early lactate-guided therapy in intensive care unit patients: a multicenter, open-label, randomized controlled trial[J]. Am J Respir Crit Care Med, 2010, 182(6):752–761.
|
| [21] |
Spahn DR, Bouillon B, Cerny V, et al. Management of bleeding and coagulopathy following major trauma: an updated European guideline[J]. Crit Care, 2013, 17(2):R76.
|
| [22] |
Vincent JL, Rhodes A, Perel A, et al. Clinical review: Update on hemodynamic monitoring -- a consensus of 16[J]. Crit Care, 2011, 15(4):229.
|
| [23] |
Vincent JL. Understanding cardiac output[J]. Crit Care, 2008, 12(4):174.
|
| [24] |
Rivers E, Nguyen B, Havstad S, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock[J]. N Engl J Med, 2001, 345(19):1368–1377.
|
| [25] |
Vincent JL, Dufaye P, Berré J, et al. Serial lactate determinations during circulatory shock[J]. Crit Care Med, 1983, 11(6):449–451.
|
| [26] |
De Backer D, Hollenberg S, Boerma C, et al. How to evaluate the microcirculation: report of a round table conference[J]. Crit Care, 2007, 11(5):R101.
|
| [27] |
Gómez H, Torres A, Polanco P, et al. Use of non-invasive NIRS during a vascular occlusion test to assess dynamic tissue O2 saturation response[J]. Intensive Care Med, 2008, 34(9):1600–1607.
|
| [28] |
Creteur J, Carollo T, Soldati G, et al. The prognostic value of muscle StO2 in septic patients[J]. Intensive Care Med, 2007, 33(9):1549–1556.
|
| [29] |
Thiele H, Zeymer U, Neumann FJ, et al. Intraaortic balloon support for myocardial infarction with cardiogenic shock[J]. N Engl J Med, 2012, 367(14):1287–1296.
|
| [30] |
Combes A, Leprince P, Luyt CE, et al. Outcomes and long-term quality-of-life of patients supported by extracorporeal membrane oxygenation for refractory cardiogenic shock[J]. Crit Care Med, 2008, 36(5):1404–1411.
|